Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Other Non-Current Liabilities (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Other Non-Current Liabilities for 16 consecutive years, with $3.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities changed N/A year-over-year to $3.6 million, compared with a TTM value of $3.6 million through Sep 2025, changed N/A, and an annual FY2024 reading of $10.1 million, down 4.58% over the prior year.
  • Other Non-Current Liabilities was $3.6 million for Q3 2025 at Cross Country Healthcare, down from $10.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $13.0 million in Q1 2023 and bottomed at $3.2 million in Q1 2025.
  • Average Other Non-Current Liabilities over 5 years is $7.9 million, with a median of $7.9 million recorded in 2022.
  • The sharpest move saw Other Non-Current Liabilities tumbled 68.21% in 2023, then skyrocketed 191.75% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $9.0 million in 2021, then dropped by 15.04% to $7.6 million in 2022, then surged by 38.67% to $10.6 million in 2023, then decreased by 4.58% to $10.1 million in 2024, then crashed by 64.66% to $3.6 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CCRN at $3.6 million in Q3 2025, $10.3 million in Q2 2025, and $3.2 million in Q1 2025.